Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag
Affiliation
Department of Medicine, University of ArizonaIssue Date
2015
Metadata
Show full item recordPublisher
HindawiCitation
Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag 2015, 2015:1 Case Reports in HematologyJournal
Case Reports in HematologyRights
Copyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproductio n in any medium, provided the original work is properly cited.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Severe refractory ITP is clinically challenging and a variety of single or combination chemotherapies have been tried with limited outcome. We report a case of ITP that was unresponsive to multiple agents including high-dose steroid, IVIG, Rho(D) immune globulin, rituximab, cyclosporine, azathioprine, vincristine, mycophenolate mofetil, romiplostim, and eltrombopag; however, it achieved complete remission with combination treatment of cyclophosphamide and eltrombopag.Description
UA Open Access Publishing FundNote
Open access.ISSN
2090-65602090-6579
Version
Final published versionAdditional Links
http://www.hindawi.com/journals/crihem/2015/583451/ae974a485f413a2113503eed53cd6c53
10.1155/2015/583451
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproductio n in any medium, provided the original work is properly cited.